Facebook Linkedin Twitter
Inside Precision Medicine CRISPR Pioneer Feng Zhang Wins $500,000 Lemelson-MIT Prize

Genetic Engineering and Biotechnology

Source: MIT
News & Features

CRISPR Pioneer Feng Zhang Wins $500,000 Lemelson-MIT Prize

0
Individumed and Helomics will partner to develop biomarkers for analyzing human cancer biospecimens and annotated patient clinical data. [Source: Individumed]
News & Features

Indivumed, Helomics Launch Cancer Biomarker Collaboration

0
cancer cell immunotherapy research
Molecular Dx

Cell Reprogramming via mRNA Nanoparticles Could Simplify, Broaden Cell Therapies

0
CRISPR Therapeutics and Massachusetts General Hospital Cancer Center said they will use CRISPR/Cas9 gene editing to develop novel T cell therapies for blood and solid tumors. [Source: Feng Zhang and Steve Dixo]
News & Features

T-Cell Immuno-Oncology Partnership Launched by CRISPR Therapeutics, Mass General

0
T-lymphocytes attacking cancer cell
News & Features

CRISPR Screening Technique Identifies 100 Genes Essential for Cancer Immunotherapy

0
Eleven professional groups have issued a policy statement urging caution
News & Features

Ruling Out Ban, Organizations Urge Caution on CRISPR Germline Genome Editing

Alex Philippidis
0
Source: herbap/Getty Images
News & Features

U.S. Researchers Correct Germline Mutation in Human Embryos via CRISPR

0
Clinical OMICs Magazine Volume 4, Issue No. 4
News & Features

Clinical OMICs Magazine Volume 4, Issue No. 4

0
CRISPR-CAS9 gene editing complex from Streptococcus pyogenes.
News & Features

UCal, European CRISPR Patent Holders Appeal U.S. Ruling

0
Researchers based at Dana-Farber/Boston Children's Cancer and Blood Disorders Center test thousands of tumor genes in mice via CRISPR
News & Features

Cancer Immunotherapy Checkpoint Escapes Identified Through CRISPR/Cas9

0
1...787980...84Page 79 of 84

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine